Reaction
Ehlers-Danlos Syndrome reporting signals
As of the last recalculation, Ehlers-Danlos Syndrome appears in 457 FAERS reports alongside 12 co-occurring drug terms. The strongest observed disproportionality signal is ASFOTASE ALFA (PRR 51.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Asfotase Alfa | 11 | 51.2 | 51.3 |
| Human Immunoglobulin G | 22 | 51.0 | 51.0 |
| Sodium Oxybate | 45 | 34.4 | 34.4 |
| Bosutinib | 6 | 30.8 | 30.8 |
| Phenobarbital | 9 | 28.8 | 28.9 |
| Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, And Amphetamine Sulfate | 19 | 25.5 | 25.5 |
| Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine Sulfate And Amphetamine Aspartate | 22 | 25.3 | 25.3 |
| Calcium, Magnesium, Potassium, And Sodium Oxybates | 4 | 21.3 | 21.3 |
| Armodafinil | 9 | 19.8 | 19.8 |
| Avapritinib | 4 | 15.2 | 15.2 |
| Galcanezumab-Gnlm | 5 | 7.3 | 7.3 |
| Copper | 3 | 3.2 | 3.2 |